Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
clinical trials
3
×
detroit blog main
detroit top stories
glaxosmithkline
3
×
immunotherapy
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
akcea therapeutics
fda
gene therapy
gilead sciences
startups
zolgensma
What
roundup
bio
nash
news
abbvie’s
according
ahead
akcea
approval
biofourmis
biogen’s
biopharmaceutical
biotech
bucks
cancer
cases
celebrate
centers
chance
cigarettes
companies
control
convo
corner
day
days
deaths
disease
drug
earlier
electronic
failures
forward
holiday
including
injuries
labor
linked
littered
looking
Language
unset
Current search:
immunotherapy
×
" clinical trials "
×
glaxosmithkline
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More